Gut bacteria pill tested to boost cancer drugs and save bladders
NCT ID NCT07474064
Summary
This study is testing if taking an oral probiotic pill can improve the effectiveness of a combination cancer drug treatment for patients with muscle-invasive bladder cancer who cannot receive standard chemotherapy. The goal is to help patients keep their bladder by controlling the cancer without needing surgery to remove it. Researchers will compare the standard two-drug combination to the same drugs plus the probiotic to see if adding the probiotic leads to better outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, 510120, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.